Journal Article DKFZ-2024-02737

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
The Progression-Free-Survival Ratio in Molecularly Aided Tumor Trials: A Critical Examination of Current Practice and Suggestions for Alternative Methods.

 ;  ;  ;  ;

2025
Wiley-VCH Berlin

Biometrical journal 67(1), e70028 () [10.1002/bimj.70028]
 GO

This record in other databases:

Please use a persistent id in citations: doi:

Abstract: The progression-free-survival ratio is a popular endpoint in oncology trials, which is frequently applied to evaluate the efficacy of molecularly targeted treatments in late-stage patients. Using elementary calculations and simulations, numerous shortcomings of the current methodology are pointed out. As a remedy to these shortcomings, an alternative methodology is proposed, using a marginal Cox model or a marginal accelerated failure time model for clustered time-to-event data. Using comprehensive simulations, it is shown that this methodology outperforms existing methods in settings where the intrapatient correlation is low to moderate. The performance of the model is further demonstrated in a real data example from a molecularly aided tumor trial. Sample size considerations are discussed.

Keyword(s): Humans (MeSH) ; Biometry: methods (MeSH) ; Neoplasms: mortality (MeSH) ; Clinical Trials as Topic: methods (MeSH) ; Progression-Free Survival (MeSH) ; Molecular Targeted Therapy: methods (MeSH) ; Models, Statistical (MeSH) ; Proportional Hazards Models (MeSH) ; Weibull distribution ; accelerated failure time model ; growth modulation index ; marginal model ; paired time‐to‐event data ; progression‐free‐survival ratio

Classification:

Note: #EA:C060#LA:C060#

Contributing Institute(s):
  1. C060 Biostatistik (C060)
  2. Translationale Medizinische Onkologie (B340)
Research Program(s):
  1. 313 - Krebsrisikofaktoren und Prävention (POF4-313) (POF4-313)

Appears in the scientific report 2025
Database coverage:
Medline ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; DEAL Wiley ; Essential Science Indicators ; IF < 5 ; JCR ; NationallizenzNationallizenz ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Public records
Publications database

 Record created 2024-12-19, last modified 2025-01-02



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)